Summit Securities Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
MFS
RC
LG
Summit Securities Group's CDLX Position: Q2 2025 in Review
Summit Securities Group sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 10 shares — an estimated $189 sold.
Summit Securities Group first reported a position in CDLX in Q3 2022 and held it in 3 quarters. The position peaked at $199K in Q4 2023. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.
- Summit Securities Group reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
- Summit Securities Group sold 10 Cardlytics shares in Q2 2025, an estimated $189.
- Summit Securities Group first reported a position in Cardlytics in Q3 2022 and held it in 3 quarters.
- Summit Securities Group's Cardlytics position peaked at $199K in Q4 2023.
- 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.
Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.